To include your compound in the COVID-19 Resource Center, submit it here.

CB-839: Updated Phase I data

Updated from a cohort of 15 evaluable patients with metastatic triple-negative breast cancer (TNBC) in the open-label,

Read the full 172 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE